|
⚲
|
| Keyboard |
| Naftzger J Christopher
✚
|
|
|---|---|
| CIK # | 0001496194 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001496194] | |
| 4 | [0001496194] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Naftzger J Christopher | |
| Arbutus Biopharma Corp | |
| Nabriva Therapeutics AG | |
| Unilife Corp |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Arbutus Biopharma Corp ABUS
Stock Option (Right to Buy) · derivative
|
2025-02-14 | Grant | 220,300 | $0.00 | |
|
Arbutus Biopharma Corp ABUS
Common Shares
|
2025-02-14 | Grant | 54,300 | $0.00 | |
|
Arbutus Biopharma Corp ABUS
Common Shares
|
2025-02-04 | Sell | 11,333 | $3.28 | 37,172 |
|
Arbutus Biopharma Corp ABUS
Stock Option (Right to Buy) · derivative
|
2024-02-01 | Grant | 380,500 | $0.00 | |
|
Arbutus Biopharma Corp ABUS
Common Shares
|
2024-02-01 | Grant | 95,100 | $0.00 | |
|
Arbutus Biopharma Corp ABUS
Stock Option (Right to Buy) · derivative
|
2023-07-10 | Grant | 500,000 | $0.00 | |
|
Nabriva Therapeutics AG NBRV
Stock Appreciation Right · derivative
|
2022-08-11 | Option exercise | 63,200 | $0.00 | |
|
Nabriva Therapeutics AG NBRV
Phantom Shares · derivative
|
2022-08-11 | Option exercise | 31,600 | $0.00 | |
|
Nabriva Therapeutics AG NBRV
Restricted Stock Units · derivative
|
2022-08-11 | Option exercise | 31,600 | $0.00 | |
|
Nabriva Therapeutics AG NBRV
Share Options · derivative
|
2022-08-11 | Option exercise | 63,200 | $0.00 | |
|
Nabriva Therapeutics AG NBRV
Share Options · derivative
|
2022-01-28 | Grant | 63,200 | $0.00 | |
|
Nabriva Therapeutics AG NBRV
Restricted Stock Units · derivative
|
2022-01-28 | Grant | 31,600 | $0.00 | |
|
Nabriva Therapeutics AG NBRV
Ordinary Shares
|
2021-12-27 | Buy | 7,000 | $0.59 | 4,130 |
|
Nabriva Therapeutics AG NBRV
Share Option · derivative
|
2021-09-30 | Grant | 100,000 | $0.00 | |
|
Unilife Corp UNIS
Common Stock
|
2013-05-28 | Grant | 165,000 | $0.00 | |
|
Unilife Corp UNIS
Common Stock
|
2012-03-20 | Grant | 17,500 | $0.00 |